Corrigendum to ‘Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2’ [European journal of medicinal chemistry 158 (2018) 814–831](S0223523418308225)(10.1016/j.ejmech.2018.09.050)
Shi, W.
European journal of medicinal chemistry2020Vol. 185pp. 0-0